2 stories about Sanofi
מייסדי Nucleai

Nucleai raises $33 million for spatial biology drug development platform

22.03.22|Meir Orbach
The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs
עומרי שור מנכ"ל מדיסייף

Medisafe raises $30 million in Series C led by pharma giant Sanofi

25.02.21|Meir Orbach
The company expanded its platform in 2020 with the launch of Medisafe Care Connector, which digitally connects patients and doctors